Insider · CIK 0001238705
Lewis H Bender
Files at INTS (INTENSITY THERAPEUTICS, INC.). First filing -, latest -.
In brief
Lewis H Bender files SEC Form 4 as CEO, president, director and 10% owner at INTS (INTENSITY THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lewis H Bender has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | INTS INTENSITY THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy Common Stock)derivative | +78,000 | $0.00 | $0 | 78,000 | Jul 20, 2026 |
| Mar 26, 2026 | INTS INTENSITY THERAPEUTICS, INC. | AGrant or award Common Stock, $0.0001 Par Value | +37,749 | $6.11 | $231k | 118,549 | Mar 30, 2026 |
| May 2, 2025 | INTS INTENSITY THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy Common Stock)derivative | +700,000 | $0.00 | $0 | 700,000 | May 6, 2025 |
Questions about Lewis H Bender
Answered from the filings on this page, as of the latest one.
Is Lewis H Bender buying or selling?
Lewis H Bender has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lewis H Bender's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lewis H Bender has 0.
Where does Lewis H Bender file Form 4?
Lewis H Bender has filed Form 4 at INTS (INTENSITY THERAPEUTICS, INC.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.